Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qin Pi Tang is a Traditional Chinese Medicine (TCM) formula, historically documented in classical texts such as the *Waitai Miyao* (Secret Essentials from the Outer Terrace). Its primary component is *Cortex Fraxini* (Qin Pi), which is often combined with other herbs like *Rhizoma Coptidis* (Huang Lian) and *Radix et Rhizoma Rhei* (Da Huang). Traditionally used to treat damp-heat conditions including dysentery and inflammatory eye diseases, modern pharmacological research has focused on its application in metabolic disorders. The formula exhibits significant anti-hyperuricemic effects by inhibiting xanthine oxidase activity and regulating renal urate transporters, making it a subject of interest for the treatment of gout and hyperuricemia. Additionally, it possesses anti-inflammatory properties mediated through the inhibition of the NF-κB signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qin pi tang.